Clinical Trials in Los Angeles

Showing 9921-9940 of 14,465 trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

This prospective observational study will evaluate the long-term safety of MabThera/Rituxan (rituximab) in participants with granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis. Data will be collected for a maximum of 4 years from participants initiated on MabThera/Rituxan therapy by their physician according to prescribing information.

Granulomatosis With PolyangiitisMicroscopic Polyangiitis

Genentech, Inc.100 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +12 more locations

COMPLETEDPhase 3< 1 mile

Open Label Study of Long Term Safety Evaluation of Alirocumab

NCT01954394

Primary Objective: To assess the long-term safety of alirocumab (SAR236553/REGN727) when added to lipid-lowering therapy in participants with heterozygous familial hypercholesterolemia (heFH) who had completed EFC12492 (NCT01623115), R727-CL-1112 (NCT01709500), EFC12732 (NCT01617655) and LTS11717 (NCT01507831). Secondary Objectives: * To evaluate the long-term efficacy of alirocumab on lipid parameters. * To evaluate the long-term immunogenicity of alirocumab.

Hypercholesterolemia

Sanofi986 participantsStarted Dec 2013

Huntsville, Alabama, United States • Tempe, Arizona, United States • Bell Gardens, California, United States +174 more locations

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Open Label Study of Long Term Safety Evaluation of Alirocumab

Find Trials by Condition in Los Angeles

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)

Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.

Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients

Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

Ideal Sedation for Stroke Thrombectomy

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines